Literature DB >> 10679840

Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates.

M M Bassiony1, M S Steinberg, A Warren, A Rosenblatt, A S Baker, C G Lyketsos.   

Abstract

OBJECTIVES: The purpose of this study was to examine the frequency of delusions and hallucinations in patients with Alzheimer's disease (AD) and to investigate factors associated with each or the combination of the two.
DESIGN: This was a cross-sectional, case-control study.
SETTING: Neuropsychiatry and Memory Group, The Johns Hopkins University, USA. PARTICIPANTS: Three hundred and forty-two community-residing patients with probable AD according to NINCDS/ADRDA criteria were included in the study. MEASURES: Patients were assessed clinically for the presence of psychotic symptoms using the DSM-IV glossary definitions. The patients were also rated on standardized measures of cognitive impairment, depression, extrapyramidal symptoms, functional impairment and general health.
RESULTS: Seventy-five (22%) AD patients had delusions only, nine (3%) had hallucinations only and 30 (9%) had both delusions and hallucinations. Hallucinations were associated with less education, African-American race, more severe dementia, longer duration of illness, falls and use of anxiolytics. Delusions were associated with older age, depression, aggression, poor general health and use of antihypertensives. Patients with both delusions and hallucinations were similar to the patients with delusions only.
CONCLUSIONS: This study confirms the high prevalence of psychotic symptoms in AD patients encountered in clinical practice and suggests that individual psychotic symptoms have different associations. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 10679840     DOI: 10.1002/(sici)1099-1166(200002)15:2<99::aid-gps82>3.0.co;2-5

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  38 in total

1.  Genetic variants associated with susceptibility to psychosis in late-onset Alzheimer's disease families.

Authors:  Sandra Barral; Badri N Vardarajan; Dolly Reyes-Dumeyer; Kelley M Faber; Thomas D Bird; Debby Tsuang; David A Bennett; Roger Rosenberg; Bradley F Boeve; Neill R Graff-Radford; Alison M Goate; Martin Farlow; Rafael Lantigua; Martin Z Medrano; Xinbing Wang; M Ilyas Kamboh; Mahmud Muhiedine Barmada; Daniel J Schaid; Tatiana M Foroud; Elise A Weamer; Ruth Ottman; Robert A Sweet; Richard Mayeux
Journal:  Neurobiol Aging       Date:  2015-08-15       Impact factor: 4.673

2.  Incident Psychosis in Subjects With Mild Cognitive Impairment or Alzheimer's Disease.

Authors:  Elise A Weamer; Mary Ann A DeMichele-Sweet; Yona K Cloonan; Oscar L Lopez; Robert A Sweet
Journal:  J Clin Psychiatry       Date:  2016-12       Impact factor: 4.384

3.  An initial study of modifiable and non-modifiable factors for late-life psychosis.

Authors:  Obiora E Onwuameze; Susan K Schultz; Sergio Paradiso
Journal:  Int J Psychiatry Med       Date:  2011       Impact factor: 1.210

4.  Gender and Pathology-Specific Effect of Apolipoprotein E Genotype on Psychosis in Alzheimer's Disease.

Authors:  Julia Kim; Corinne E Fischer; Tom A Schweizer; David G Munoz
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

5.  The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration.

Authors:  J Ellul; N Archer; C M L Foy; M Poppe; H Boothby; H Nicholas; R G Brown; S Lovestone
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-29       Impact factor: 10.154

Review 6.  Organic psychosis: Insight into the biology of psychosis.

Authors:  N T Lautenschlager; H Förstl
Journal:  Curr Psychiatry Rep       Date:  2001-08       Impact factor: 5.285

7.  Effects of Vitamin D Use on Outcomes of Psychotic Symptoms in Alzheimer Disease Patients.

Authors:  Lirong Wang; Jian Ying; Peihao Fan; Elise A Weamer; Mary Ann A DeMichele-Sweet; Oscar L Lopez; Julia K Kofler; Robert A Sweet
Journal:  Am J Geriatr Psychiatry       Date:  2019-03-27       Impact factor: 4.105

8.  Current electroconvulsive therapy practice and research in the geriatric population.

Authors:  Nancy Kerner; Joan Prudic
Journal:  Neuropsychiatry (London)       Date:  2014-02

9.  Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.

Authors:  Katherine A Treiber; Constantine G Lyketsos; Chris Corcoran; Martin Steinberg; Maria Norton; Robert C Green; Peter Rabins; David M Stein; Kathleen A Welsh-Bohmer; John C S Breitner; JoAnn T Tschanz
Journal:  Int Psychogeriatr       Date:  2008-02-21       Impact factor: 3.878

10.  Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.

Authors:  Martin Steinberg; Kyle Hess; Chris Corcoran; Michelle M Mielke; Maria Norton; John Breitner; Robert Green; Jeannie Leoutsakos; Kathleen Welsh-Bohmer; Constantine Lyketsos; Joann Tschanz
Journal:  Int J Geriatr Psychiatry       Date:  2013-05-17       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.